aMonoclonal antibody | Number of subjects | cInfection | dAntibodies to rMSP1 | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Total n = 147 | bInfected | M | S | MOI | Prevalence | P | Mean log titre | P |
12.8 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Poorly competitive (L) | 100 | 99 | 50 | 49 | 1.73 | 78% | 0.0006 | 2.3 | 0.0001 |
Highly competitive (H) | 46 | 43 | 22 | 21 | 1.65 | 100% | Â | 3.2 | Â |
12.10 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Poorly competitive (L) | 90 | 87 | 38* | 49 | 0.86 | 77% | 0.002 | 2.4 | 0.0001 |
Highly competitive (H) | 57 | 56 | 35 | 21 | 0.98 | 96% | Â | 2.9 | Â |
12.8 and 12.10 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Poorly competitive (L) | 75 | 74 | 33 ** | 41 | 1.62 | 73% | 0.0007 | 2.3 | 0.0001 |
Highly competitive (H) | 32 | 31 | 18 | 13 | 1.77 | 100% | Â | 3.2 | Â |